The value of an infectious diseases specialist

Clinical Infectious Diseases

Volumn 36, Issue 8, 2003, Pages 1013-1017

  Petrak, Russell M ^a   Sexton, Daniel J ^c   Butera, Michael L ^d   Tenenbaum, Marvin J ^f   MacGregor, Mary C ^b   Schmidt, Mary E ^g   Joseph, W Patrick ^e   Kemmerly, Sandra A ^h   Dougherty, Mark J ⁱ   Bakken, Johan S ^j   Curfman, Maria F ^k   Martinelli, Lawrence P ^l   Gainer, R Brooks ^m  

^a Metro Infectious Disease Consultants   (United States)

^b Travel Medicine Source   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d ID Association of California   (United States)

^e ID Medical Group   (United States)

^f ID Consultants   (United States)

^g ID Consultants   (United States)

^h OCHSNER CLINIC FOUNDATION   (United States)

ⁱ Lexington Cardiology Consultants   (United States)

^j Duluth Clinic   (United States)

^k Fort Wayne Metals   (United States)

^l Lubbock Electric Co Inc   (United States)

^m Morgantown Internal Medicine Group   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; CONSULTATION; EXPERIENCE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; INFECTION; INFECTION CONTROL; MEDICAL SPECIALIST; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL; SEPSIS; SKILL; COMMUNICABLE DISEASE; ECONOMICS; HUMAN; MEDICAL PROFESSION;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; HUMANS; INFECTION CONTROL; OUTPATIENTS; SEPSIS; SPECIALISM;

EID: 0037445553     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374245     Document Type: Article

References (49)

1. Greenfield S, Nelson EC, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care: results from the medical outcomes study. JAMA 1992; 267:1624-30.
2. Classen DC, Burke JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of preliminary study. Clin Infect Dis 1997; 24:468-70.
3. Wenzel RT. The value of infectious disease specialists. Clin Infect Dis 1997; 24:456.
4. Sexton DJ. Rates of infectious disease consultation in hospitals of different size and types, 1986-87. Rev Infect Dis 1991; 13:527.
5. Yinnon AM. Wither infectious disease consultations? Analysis of 14,500 consultations from a 5-year period. Clin Infect Dis 2001; 33:1661-7.
6. Wilkins EG, Hickey MM, Khoo S, et al. Northwood Park Infection Control Consultation Service. Park II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect 1991; 23:57-63.
7. Cotton ME. Telephone calls to an infectious disease fellow. Pediatrics 1995; 95:753-4.
8. Kleiman MB. The infectious disease consultant and the telephone consultations. Pediatr Infect Dis 1986; 5:51-3.
9. Manian F, McKinsey D. A prospective study of 2,092 "curbside" questions asked of two infectious disease consultants in private practice in the Midwest. Clin Infect Dis 1996; 22:303-7
10. Raz R, Sobah S, Bisharat N. Current topics of curbside consultations on infectious disease. Infect Dis Clin Pract 1999; 9:292-4.
11. Lobati F, Herndon B, Bamberger D. Osteomyelitis: etiology, diagnosis, treatment and outcome in a public versus a private institution. Infection 2001; 29:93-6.
12. Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch Intern Med 2001; 161:61-5.
13. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteremia due to urinary tract infection. J Infect 1997; 35:283-8.
14. Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478-86.
15. Kitahata MM, Koepsell TD, Deyo RA. Physician's experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996; 334:701-6.
16. Frank MO, Batteiger BE, Sorenson SJ, et al. Decrease in expenditures and selected nosocomial infections following implementation of an anti-microbial prescribing improvement program. Clin Perform Qual Health Care 1997; 5:180-8.
17. Fox BC, Imrey PB, Voights MB, Norwood S. Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001; 33:1981-9.
18. Doern GV, Vautour R, Gaudet M, et al. Clinical impact of rapid in vitro susceptibiIity testing and bacterial identification. J Clin Microbiol 1994; 32:1757-62.
19. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotics sensitivities in patients with community-acquired bacteremia due to urinary tract infection. J Infect 1997; 35:283-8.
20. Gomez J, Conde Cavero SJ, Hernandez JL, et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 1996; 38:309-14.
21. Byl B, Clevenbergh P, Jacobs F, et al. Impact of infectious disease specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29:60-6.
22. Nathwani D, Davey P, France AJ, et al. Impact of an infection consultation service for bacteremia on clinical management and use of resources. QJM 1996; 89:789-97.
23. Fluckiger U, Zimmmerli W, Sax H, et al. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000; 19:493-500.
24. Gomez J, Conde Cavera SJ, Hernandex Cardona JL, et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother 1996; 38:309-14.
25. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
26. Looney MR, Matthay MA. The role of protein C in sepsis. Curr infect Dis Rep 2001; 3:413-8.
27. Alberio L, Lammle B, Esmon CT. Protein C replacement in severe meningococcemia: rationale and clinical experience. Clin Infect Dis 2001; 32:1338-46.
28. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-72.
29. Farr BM. Preventing vascular catheter-related infections: current controversies. Clin Infect Dis 2001; 33:1733-8.
30. Dunagon WC, Murphy DM, Hollenbeak CS. Making the business case for infection control: pitfalls and opportunities. Am J Infect Control 2002; 30:86-92.
31. Fraser VJ, Olsen MA. The business of health care epidemiology: creating a vision for service excellence. Am J Infect Control 2002; 30:77-85.
32. Wenzel RP. The economics of nosocomial infections. J Hosp Infect 1995; 31:79-87.
33. Slama TG, Sexton DJ, Ingram CW, et al. Findings of the 1998 Infectious Diseases Society of America membership survey. Clin Infect Dis 2000; 31:1396-402.
34. Kirkland KB, Briggs JR, Trivette SL, Wilkinson WP, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-30.
35. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WI, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23:183-9.
36. Deery HG II. Negotiating with administration - or how to get paid for doing hospital epidemiology. Infect Control Hosp Epidemiol 1997; 18:209-14.
37. Wade BH. Outpatient/out of hospital care issues. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1997:243-59.
38. Herwaldt LA, Smith SD, Carter CD. Infection control in the outpatient setting. Infect Control Hosp Epidemiol 1998; 19:41-74.
39. Bolinsky U, Nesbitt S. Cost effectiveness of outpatient parenteral antibiotics: a review of the literature. Am J Med 1989; 87:301-9.
40. Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis: economic analysis of a therapeutic strategy. JAMA 1986; 255:1584-8.
41. Grainger-Rousseau TJ, Segal R. Economic, clinical and psychosocial outcomes of home infusion therapy: a review of published studies. Pharm Pract Manage Q 1995; 15:57-77.
42. Williams DN, Bosch D, Boots J, et al. Safety, efficacy and cost savings in an outpatient intravenous antibiotic program. Clin Ther 1993; 15:169-79.
43. Williams DN, Rehm SJ, Tice AD, et al. Practice guidelines for community-based parenteral anti-infective therapy. Clin Infect Dis 1997; 25:787-801.
44. Briceland LD, Nightengale CH, Quintiliani R, et al. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 1988; 148:2019-22.
45. Fox BC, Imrey PB, Voights MB, Norwood S. Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001; 33:1981-9.
46. McGowan JE Jr, Finland M. Effects of monitoring usage of antibiotics: an interhospital comparison. South Med J 1976; 69:193-5.
47. White AL, Altmer RL, Wilson J, Cate TR, Stayer CE, Greeberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 1997; 25:230-9.
48. Ehrenkranz NJ, Nerinberg DE, Shultz JM, Slater VE. Intervention to discontinue parenteral antlmicrobial therapy in hospitalized patients with pulmonary infections: effect on shortening patient stay. Infect Control Hosp Epidemiol 1992; 13:21-32.
49. Quintiliani R, Cooper BW, Briceland LL, et al. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82(Suppl 4A):391-4.